Charts Aptose Biosciences Inc. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 11:45:06 2026-06-18 am EDT			5-day change	1st Jan Change
1.560 ^USD	-3.26%		-3.26%	+5.41%

Jun. 15	Aptose Biosciences Inc. Presents Safety, Response and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML	CI
Jun. 15	Aptose Biosciences Updated Tuscany Trial Data Reported in Oral Presentation at EHA 2026	MT

ProRealTime Chart